Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Eir
  6. /
  7. Cordis US Corp
EIR
•Cordis US Corp•March 31, 2016

Cordis US Corp – FDA EIR, Mar 31, 2016

Record Details

The Level II risk-based inspection of Cordis Corporation's Miami Lakes facility, conducted from March 24 to March 31, 2016, focused on its role as a medical device component manufacturer, complaint handling facility, and sterilization record reviewer for Class II and III cardiovascular and endovascular devices. It assessed compliance with the Quality System (QS) regulations and Medical Device Reporting (MDR) requirements, specifically reviewing Management Controls, Corrective and Preventive Actions (CAPA), and Production and Process Controls. The regulatory framework for this inspection was Compliance Program 7382.845, Inspection of Medical Device Manufacturers. Although no formal FDA-483 "Inspectional Observations" were issued, the inspection concluded with verbal observations. These centered on failures to maintain accurate eMDR communications for adverse event reports, inconsistencies in investigation documentation, and a lack of relevant information in some complaint investigations. Previous inspection observations had been appropriately corrected. Cordis Corporation management acknowledged the verbal observations, affirming their commitment to comply with FDA regulations and promising prompt corrective actions. The FDA investigator underscored management's responsibility to thoroughly investigate and address the root causes of these issues with permanent corrective actions, particularly regarding organizational structure, quality audits, management reviews, quality policy implementation, and training. The potential for further agency enforcement actions was also conveyed.

Company
Cordis US Corp
Inspection date
March 31, 2016
Product type
devices
Office
Florida District Office
Person
  • Dianiris C. Ayala
View Company Profile

ID · 72f88d8c-dcc3-4138-95f2-64b9fb275f5f

Violation Codes4
21 CFR 820.19821 CFR 82021 CFR 820.10021 CFR 803

Full citation text and observation details available on the Dashboard.

Other documents for Cordis US Corp
  • 483 - 2022-06-29June 29, 2022
  • EIR - 2014-01-30January 30, 2014

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Cordis US Corp
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.